FPR2 and colitis: For example, Bento and colleagues reported that the ALX/FPR2 inhibitor Boc-1 abolishes the anti-inflammatory effects of aspirin-triggered resolvin D1 on LPS-stimulated macrophages derived from murine bone marrow, thereby exacerbating murine DSS-induced colitis [37].